Cargando…

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline

STUDY OBJECTIVE: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) cholesterol guideline recommends a maximally-tolerated statin with add-on lipid-lowering therapy, ezetimibe and/or proprotein convertase subtilisin/kexin type 9 (PCSK9) for adults with very-high atheroscler...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alanaeme, Chibuike J., Bittner, Vera, Brown, Todd M., Colantonio, Lisandro D., Dhalwani, Nafeesa, Jones, Jenna, Kalich, Bethany, Exter, Jason, Jackson, Elizabeth A., Levitan, Emily B., Poudel, Bharat, Wang, Zhixin, Woodward, Mark, Muntner, Paul, Rosenson, Robert S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10168648/ https://www.ncbi.nlm.nih.gov/pubmed/37168932 http://dx.doi.org/10.1016/j.ahjo.2022.100201

Ejemplares similares

Comparison of the association of masked hypertension defined by the 2017 ACC/AHA BP guideline versus the JNC7 guideline with left ventricular hypertrophy
por: Poudel, Bharat, et al.
Publicado: (2022)

Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2023)

Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study
por: Poudel, Bharat, et al.
Publicado: (2021)

AHA/ACC/Multisociety Cholesterol Guidelines: highlights
por: Jialal, Ishwarlal, et al.
Publicado: (2019)

Comparison of ESC and ACC/AHA guidelines for myocardial revascularization
por: Stirrup, Jim, et al.
Publicado: (2017)

Representation of cardiovascular magnetic resonance in the AHA / ACC guidelines
por: von Knobelsdorff-Brenkenhoff, Florian, et al.
Publicado: (2017)

Trends in Utilization of Statin Therapy and Contraindicated Statin Use in HIV‐‐Infected Adults Treated With Antiretroviral Therapy From 2007 Through 2015
por: Rosenson, Robert S., et al.
Publicado: (2018)

Management of the ACC/AHA Stage D Patient: Cardiac Transplantation
por: Kittleson, Michelle M., et al.
Publicado: (2014)

Machine Learning Outperforms ACC/AHA CVD Risk Calculator in MESA
por: Kakadiaris, Ioannis A., et al.
Publicado: (2018)

Are the guidelines of the ISH devoted to a population not contemplated in the ACC/AHA guidelines?
por: Ruilope, Luis M., et al.
Publicado: (2020)

Incident cerebral microbleeds and hypertension defined by the 2017 ACC/AHA Guidelines
por: Xia, Yiwei, et al.
Publicado: (2021)

Preventive cardiology advances in the 2021 AHA/ACC chest pain guideline
por: Cardoso, Rhanderson, et al.
Publicado: (2022)

Doctors’ knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in Singapore
por: Setia, Sajita, et al.
Publicado: (2015)

Association Between Triglycerides and Incident Cognitive Impairment in Black and White Adults in the Reasons for Geographic and Racial Differences in Stroke Study
por: Rosenson, Robert S., et al.
Publicado: (2023)

Recalibration of the ACC/AHA Risk Score in Two Population-Based German Cohorts
por: de las Heras Gala, Tonia, et al.
Publicado: (2016)

Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study
por: Arshi, Banafsheh, et al.
Publicado: (2021)

ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison
por: Behnoush, Amir Hossein, et al.
Publicado: (2022)

Excess Risk for Atherosclerotic Cardiovascular Outcomes Among US Adults With HIV in the Current Era
por: Rosenson, Robert S., et al.
Publicado: (2019)

Estimated Change in Prevalence of Hypertension in Nepal Following Application of the 2017 ACC/AHA Guideline
por: Kibria, Gulam Muhammed Al, et al.
Publicado: (2018)

Female‐friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
por: Wenger, Nanette K.
Publicado: (2019)

Prevalence of high blood pressure in Iranian adults based on the 2017 ACC/AHA guideline
por: Hosseini, Mostafa, et al.
Publicado: (2019)

What is new in ACC/AHA 2017 focused update of valvular heart disease guidelines
por: Özkan, Mehmet
Publicado: (2017)

Society for Cardiovascular Magnetic Resonance perspective on the 2021 AHA/ACC Chest Pain Guidelines
por: Arai, Andrew E., et al.
Publicado: (2022)

Comparison of the ACC/AHA and Framingham algorithms to assess cardiovascular risk in HIV-infected patients
por: Pinto Neto, Lauro Ferreira da Silva, et al.
Publicado: (2017)

External validation of the ACC/AHA ASCVD risk score in a Colombian population cohort
por: Rodríguez-Ariza, Carlos Daniel, et al.
Publicado: (2023)

Adherence to the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline on the Use of Oral Anticoagulant Agents in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
por: Hammoudeh, Ayman J., et al.
Publicado: (2021)

The 2017 ACC/AHA stage 1 hypertension is associated with arterial stiffness: a prospective analysis
por: Liu, Shanshan, et al.
Publicado: (2021)

Prevalence of and factors associated with hypertension according to JNC 7 and ACC/AHA 2017 guidelines in Bangladesh
por: Rahman, Md. Ashfikur, et al.
Publicado: (2021)

Thoracic Aortic Calcification and Pre-Clinical Hypertension by New 2017 ACC/AHA Hypertension Guidelines
por: Jan, Ya-Ting, et al.
Publicado: (2021)

2021 ACC/AHA/SCAI Coronary Artery Revascularization Guidelines for Managing the Nonculprit Artery in STEMI
por: Don, Creighton W., et al.
Publicado: (2022)

Statins utilization trends and expenditures in the U.S. before and after the implementation of the 2013 ACC/AHA guidelines
por: Matyori, Amro, et al.
Publicado: (2023)

The AHA/ACC/HFSA 2022 Heart Failure Guidelines: Changing the Focus to Heart Failure Prevention
por: Abovich, Arielle, et al.
Publicado: (2023)

Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
por: Hubbard, Demetria, et al.
Publicado: (2021)

Healthcare Utilization and Statin Re‐Initiation Among Medicare Beneficiaries With a History of Myocardial Infarction
por: Booth, John N., et al.
Publicado: (2018)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
Publicado: (2016)

2013 ACC/AHA Cholesterol Guideline and Implications for Healthy People 2020 Cardiovascular Disease Prevention Goals
por: Egan, Brent M., et al.
Publicado: (2016)

Blood Pressure Control and Cardiovascular Outcomes: Real-world Implications of the 2017 ACC/AHA Hypertension Guideline
por: Lee, Ji Hyun, et al.
Publicado: (2018)

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
por: Asgari, Samaneh, et al.
Publicado: (2019)

Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19
por: Bozkurt, Biykem, et al.
Publicado: (2020)

Validation of the 2020 AHA/ACC Risk Stratification for Sudden Cardiac Death in Chinese Patients With Hypertrophic Cardiomyopathy
por: Dong, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sbaaig0ns59g3ht81f64upitgo